✦ LIBER ✦

243 A phase II study of the recombinant human interleukin 3 (IL-3) following carboplatin (CBDCA) and etoposide (VP-16) chemotherapy in patients with small cell lung cancer (SCLC)

✍ Scribed by S. Kudo; N. Kurihara; K. Furuse; Y. Kurita; M. Fukuoka; M. Takada; F. Takaku; M. Ogawa; Y. Ariyoshi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of recombinant human inte

✍ S. Kudoh; Toshiyuki Sawa; Naotsugu Kurihara; Kiyoyuki Furuse; Yuzo Kurita; Masah 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 138 KB

A Phase II Double-Blind Randomized Study

✍ Howard Hochster; James L. Speyer; John P. Mandeli; Carolyn Runowicz; Scott Wadle 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 51 KB

P-792 Phase II study of cisplatin plus e

✍ Samantas, E.; Syrigos, K.; Briassoulis, E.; Bamias, A.; Koutras, A.; Karina, M.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB